Open AccessReal-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis
Author(s) -
Enayatullah Baki,
Philipp Zwickel,
Anna Zawierucha,
Robert Ehehalt,
Daniel Gotthardt,
Wolfgang Stremmel,
Annika Gauss
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i11.3282
Subject(s) - medicine , infliximab , ulcerative colitis , adalimumab , discontinuation , colectomy , adverse effect , surgery , gastroenterology , tumor necrosis factor alpha , disease
To evaluate the outcome of anti-tumor necrosis factor alpha (anti-TNFα) therapy in outpatients with ulcerative colitis at a tertiary referral center.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom